Skip to main content
Bastide Le Confort Médical logo

Bastide Le Confort Médical — Investor Relations & Filings

Ticker · BLC ISIN · FR0000035370 LEI · 969500RC3F6AGLE5IT57 PA Human health and social work activities
Open in API
Filings indexed 545 across all filing types
Latest filing 2026-05-21 M&A Activity
Country FR France
Listing PA BLC

About Bastide Le Confort Médical

https://bastide-groupe.fr

Bastide Le Confort Médical is a provider of home healthcare services and medical-technical solutions. The company specializes in the sale and rental of medical equipment and supplies for individuals—including the elderly, ill, and handicapped—as well as for healthcare professionals and facilities. Its core activities encompass several specialized areas: respiratory assistance (sleep apnea, oxygen therapy), diabetes care, nutrition and perfusion support, and post-operative care (urology, wound management). A primary focus is on home care, offering a comprehensive range of products and services designed to support patient autonomy, comfort, and well-being outside of traditional hospital settings.

Recent filings

Filing Released Lang Actions
Le Groupe Bastide conclut une promesse d'achat avec Sapio Group en vue de la cession de New Medical Concept, holding du groupe EXPERF - Erratum
M&A Activity Classification · 85% confidence The document is a press release announcing the sale (cession) of the subsidiary New Medical Concept (group EXPERF) by Groupe Bastide to Sapio Group. It details the transaction terms, strategic rationale, advisors, and expected financial impact, with no full financial statements or investor call transcripts. This is a corporate transaction announcement (divestiture), fitting the M&A Activity category.
2026-05-21 French
Groupe Bastide sells New Medical Concept, the holding company of EXPERF group - Erratum
M&A Activity Classification · 85% confidence The document is a corporate press release announcing the signing of an agreement for the disposal (sale) of a subsidiary (EXPERF) by Groupe Bastide. This is a transaction announcement involving M&A activity—specifically the sale of a business unit—rather than a financing update, earnings release, dividend notice, or regulatory filing. Therefore, it best fits the M&A Activity category.
2026-05-21 English
Groupe Bastide sells New Medical Concept, the holding company of EXPERF group - Erratum
M&A Activity Classification · 65% confidence The document is a press release announcing the disposal (sale) of a subsidiary (New Medical Concept / EXPERF group) to Sapio Group. This constitutes M&A activity (an acquisition by Sapio and divestiture by Bastide). It is not an earnings release (no standalone financial highlights only), not a report attachment announcement, and not a financing raise. Therefore, the best match is M&A Activity (TAR).
2026-05-21 English
Le Groupe Bastide conclut une promesse d'achat avec Sapio Group en vue de la cession de New Medical Concept, holding du groupe EXPERF - Erratum
M&A Activity Classification · 95% confidence The document is a corporate press release announcing the signing of an agreement for the sale (cession) of its subsidiary New Medical Concept (EXPERF) to Sapio Group. This is clearly an announcement of an M&A transaction. It is not a full annual or interim report, earnings release, financing update, or regulatory form. Therefore it falls under M&A Activity.
2026-05-21 French
Groupe Bastide sells New Medical Concept, the holding company of EXPERF group
Regulatory Filings Classification · 72% confidence The document is a press release (communiqué de presse) announcing the disposal of a subsidiary (asset sale) by Groupe Bastide. It contains no financial statements, no dividends, no director appointments, no ESG or governance details, and is not an AGM or earnings release. It is a general corporate/regulatory announcement and does not map to any more specific category, so it falls under the fallback “Regulatory Filings (RNS).”
2026-05-21 English
Le Groupe Bastide conclut une promesse d'achat avec Sapio Group en vue de la cession de New Medical Concept, holding du groupe EXPERF
M&A Activity Classification · 92% confidence The document is a corporate press release announcing the sale (cession) of its subsidiary New Medical Concept (group EXPERF) from Groupe Bastide to Sapio Group. It describes transaction terms, strategic rationale, advisors, and conditions precedent. This aligns with announcements related to M&A activity rather than a full merger proxy or regulatory tender offer filing. Therefore it is classified as M&A Activity (Code: TAR).
2026-05-21 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.